Company Filing History:
2 out of 3 
1 out of 1 
1 out of 3 Years Active: 2010-2015
Title: Richard Kanner: Innovator in Acetylcholine Modulation
Introduction
Richard Kanner is a notable inventor based in Santa Ana, CA (US). He has made significant contributions to the field of pharmacology, particularly in the development of allosteric modulators for the α7 nicotinic acetylcholine receptor. With a total of 4 patents to his name, Kanner's work has the potential to impact the treatment of various disorders.
Latest Patents
Kanner's latest patents focus on α7 nicotinic acetylcholine receptor allosteric modulators and their derivatives. These compounds, represented by Formula I, are novel allosteric modulators of α7nAChR. The applications disclose methods for treating disorders that respond to the modulation of acetylcholine action on α7nAChR in mammals by administering an effective amount of a compound of Formula I.
Career Highlights
Throughout his career, Richard Kanner has worked with several companies, including Anvyl, LLC and Mpg Biotechnologies, LLC. His expertise in pharmacology and innovative approaches to drug development have positioned him as a key figure in his field.
Collaborations
Kanner has collaborated with various professionals, including his coworker Roger A Acey. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Richard Kanner's contributions to the field of pharmacology through his innovative patents highlight his role as a significant inventor. His work on α7 nicotinic acetylcholine receptor allosteric modulators showcases the potential for advancements in medical treatments.